Cartesian Therapeutics, Inc. (RNAC)
USD 12.7
(3.5%)
USD 12.7
(3.5%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -65.95 Million USD | 3.73% |
| 2022 | -68.51 Million USD | 13.03% |
| 2021 | -78.77 Million USD | 23.77% |
| 2020 | -103.33 Million USD | -45.76% |
| 2019 | -70.89 Million USD | -342.6% |
| 2018 | -16.01 Million USD | 67.74% |
| 2017 | -49.65 Million USD | -6.35% |
| 2016 | -46.69 Million USD | -126.49% |
| 2015 | -20.61 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -92.96 Million USD | -40.94% |
| 2023 Q1 | -88.19 Million USD | -28.18% |
| 2023 Q2 | -77.11 Million USD | 12.56% |
| 2023 Q3 | -69.12 Million USD | 10.36% |
| 2023 FY | -65.95 Million USD | 3.73% |
| 2023 Q4 | -65.95 Million USD | 4.58% |
| 2022 Q1 | -78.29 Million USD | 0.61% |
| 2022 Q4 | -68.8 Million USD | 7.88% |
| 2022 Q3 | -74.69 Million USD | 27.48% |
| 2022 Q2 | -102.99 Million USD | -31.55% |
| 2022 FY | -68.51 Million USD | 13.03% |
| 2021 Q2 | -90.4 Million USD | -0.4% |
| 2021 FY | -78.77 Million USD | 23.77% |
| 2021 Q4 | -78.77 Million USD | 0.7% |
| 2021 Q3 | -79.33 Million USD | 12.25% |
| 2021 Q1 | -90.05 Million USD | 0.0% |
| 2020 FY | -103.33 Million USD | -45.76% |
| 2019 FY | -70.89 Million USD | -342.6% |
| 2018 FY | -16.01 Million USD | 67.74% |
| 2017 FY | -49.65 Million USD | -6.35% |
| 2016 FY | -46.69 Million USD | -126.49% |
| 2015 FY | -20.61 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -828.958% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 57.212% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -313.958% |
| Autolus Therapeutics plc | -186.59 Million USD | 64.654% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -843.654% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 62322.642% |
| Shattuck Labs, Inc. | -121.42 Million USD | 45.681% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 64.444% |
| CervoMed Inc. | -7.79 Million USD | -746.366% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -113.713% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1046.545% |
| Aptose Biosciences Inc. | -8.19 Million USD | -704.846% |
| Precision BioSciences, Inc. | -85.41 Million USD | 22.777% |
| Dyadic International, Inc. | -6.37 Million USD | -934.101% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -61.159% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -685.377% |
| Nektar Therapeutics | 210.24 Million USD | 131.372% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -1963.059% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -116.533% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 76.085% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 6.287% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 140.127% |
| GRI Bio, Inc. | -1.79 Million USD | -3576.477% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -634.228% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -98.322% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -2498.739% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1056.633% |
| IGM Biosciences, Inc. | -72.6 Million USD | 9.159% |
| INmune Bio, Inc. | -25.41 Million USD | -159.557% |
| Opthea Limited | 28.15 Million USD | 334.24% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 273.5% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 209.954% |
| Verastem, Inc. | -37.27 Million USD | -76.93% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -626.948% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -27.176% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -335.785% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -292.852% |
| NextCure, Inc. | -6.47 Million USD | -918.311% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -672.031% |
| Organovo Holdings, Inc. | -1.5 Million USD | -4276.642% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -1469.078% |
| Arvinas, Inc. | -313.8 Million USD | 78.982% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 447.865% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 1687.007% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 377.885% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -51.825% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 79.18% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 14.842% |
| Senti Biosciences, Inc. | 1.74 Million USD | 3890.575% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -9034.421% |
| Apollomics, Inc. | -27.39 Million USD | -140.759% |
| PureTech Health plc | -167.19 Million USD | 60.552% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -933.955% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 48.916% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -160.778% |
| Synaptogenix, Inc. | -28.66 Million USD | -130.121% |
| ChromaDex Corporation | -24.04 Million USD | -174.268% |
| Beam Therapeutics Inc. | -262.72 Million USD | 74.895% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -807.725% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 207.671% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -174.668% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 72.674% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -786.728% |
| Gritstone bio, Inc. | 39.49 Million USD | 267.019% |
| Mesoblast Limited | 55.96 Million USD | 217.856% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -621.5% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 140.779% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 206.957% |
| MediWound Ltd. | -5.32 Million USD | -1139.309% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 282.385% |
| Fortress Biotech, Inc. | 7.66 Million USD | 960.483% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 119.388% |
| Achilles Therapeutics plc | -126.92 Million USD | 48.035% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 176.719% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -1238.393% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 25.44% |
| Zai Lab Limited | -775 Million USD | 91.49% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -506.883% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 20.034% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 47.827% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 65.864% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 110.333% |
| FibroGen, Inc. | 56.76 Million USD | 216.187% |
| Celcuity Inc. | 6.78 Million USD | 1072.299% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 840.663% |
| ContextLogic Inc. | -232 Million USD | 71.571% |
| GH Research PLC | -78.07 Million USD | 15.524% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 40.331% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -1874.139% |
| ImmuCell Corporation | 10.99 Million USD | 700.115% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 60.259% |
| Amarin Corporation plc | -191.04 Million USD | 65.475% |
| TG Therapeutics, Inc. | 17.86 Million USD | 469.253% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -473.182% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 21.575% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -87.04% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 14.585% |
| Aptorum Group Limited | 1.35 Million USD | 4960.263% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 61.297% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 108.958% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -634.8% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 1641.028% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -2746.579% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -62.565% |
| Ardelyx, Inc. | 34.51 Million USD | 291.11% |
| Ainos, Inc. | 4.07 Million USD | 1717.39% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 1556.625% |
| Prothena Corporation plc | -608.34 Million USD | 89.158% |
| HilleVax, Inc. | -165.48 Million USD | 60.144% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 44.461% |
| Celularity Inc. | 65.19 Million USD | 201.175% |
| Rallybio Corporation | -24.1 Million USD | -173.654% |
| Cue Biopharma, Inc. | -33.81 Million USD | -95.026% |
| Omeros Corporation | 331.17 Million USD | 119.916% |
| Humacyte, Inc. | -22.48 Million USD | -193.32% |
| Immunocore Holdings plc | -358.59 Million USD | 81.607% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -168.387% |
| Blueprint Medicines Corporation | 702.83 Million USD | 109.384% |
| IO Biotech, Inc. | -140.69 Million USD | 53.123% |
| MEI Pharma, Inc. | -3.7 Million USD | -1680.189% |
| GT Biopharma, Inc. | -1.02 Million USD | -6359.941% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 64.958% |
| Summit Therapeutics Inc. | 34.67 Million USD | 290.217% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -988.024% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -545.741% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -64.738% |
| Pulmatrix, Inc. | -10.41 Million USD | -533.157% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -1003.497% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -60.146% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -72.922% |
| Acelyrin, Inc. | -216.9 Million USD | 69.592% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 40.795% |
| Cytokinetics, Incorporated | 642.37 Million USD | 110.268% |
| Vor Biopharma Inc. | 4.3 Million USD | 1633.86% |
| Evogene Ltd. | -19.63 Million USD | -235.927% |
| Replimune Group, Inc. | 1.41 Million USD | 4771.105% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -35.511% |
| PDS Biotechnology Corporation | -32.7 Million USD | -101.645% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -614.027% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 104.836% |
| AEON Biopharma, Inc. | -4.88 Million USD | -1251.557% |
| BioLineRx Ltd. | 7.33 Million USD | 999.073% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 242.926% |
| Atai Life Sciences N.V. | -28.55 Million USD | -130.955% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -189.078% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 43.65% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 471.897% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 12.145% |
| MediciNova, Inc. | -50.78 Million USD | -29.877% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 16.305% |
| MiMedx Group, Inc. | -33.9 Million USD | -94.555% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -293102.934% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 66.992% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 63.148% |
| Mereo BioPharma Group plc | -51.46 Million USD | -28.147% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 77.548% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 1544.503% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 29.991% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -7550.718% |
| Allakos Inc. | -24.97 Million USD | -164.088% |
| scPharmaceuticals Inc. | -6.54 Million USD | -907.731% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -347.402% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 51.288% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 9060.61% |
| Precigen, Inc. | -481 Thousand USD | -13612.266% |
| XOMA Corporation | -29 Million USD | -127.434% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -298.285% |
| Incyte Corporation | -3.17 Billion USD | 97.923% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -87451.438% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -631.544% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 47.081% |
| Seer, Inc. | -4.24 Million USD | -1455.566% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -256.137% |
| CRISPR Therapeutics AG | -150.84 Million USD | 56.276% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 68.315% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 28.898% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -7576.586% |
| Akari Therapeutics, Plc | -3.84 Million USD | -1615.371% |
| Novavax, Inc. | -298.29 Million USD | 77.889% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -5451.221% |
| UroGen Pharma Ltd. | 4.39 Million USD | 1602.072% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 158.121% |
| Entera Bio Ltd. | -10.62 Million USD | -520.529% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -195.926% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 64.272% |
| Chimerix, Inc. | -25.51 Million USD | -158.479% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -147.406% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 72.786% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 642.256% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 101.437% |
| AnaptysBio, Inc. | -18.15 Million USD | -263.374% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -205.255% |
| Portage Biotech Inc. | -4.98 Million USD | -1224.152% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 0.251% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -161.295% |
| OKYO Pharma Limited | -826.84 Thousand USD | -7876.799% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 7449.57% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -686.956% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -1347.787% |
| AbCellera Biologics Inc. | -55.94 Million USD | -17.905% |
| Genprex, Inc. | -6.73 Million USD | -878.92% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 82.116% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 9060.61% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -1888.456% |
| Daré Bioscience, Inc. | -5.15 Million USD | -1178.735% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -962.436% |
| Bicycle Therapeutics plc | -481.46 Million USD | 86.301% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 89.156% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 64.461% |
| Erasca, Inc. | -37.21 Million USD | -77.225% |
| bluebird bio, Inc. | 108.57 Million USD | 160.749% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -279.145% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 117.414% |
| DBV Technologies S.A. | -126.98 Million USD | 48.06% |
| Fortress Biotech, Inc. | 7.66 Million USD | 960.483% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 62.36% |
| CorMedix Inc. | -43.05 Million USD | -53.199% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 119.029% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -869.513% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -128.443% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 28.098% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -104.375% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -91.866% |
| Onconetix, Inc. | 5.33 Million USD | 1337.115% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -30.603% |
| Prime Medicine, Inc. | -27.94 Million USD | -136.055% |
| Adagene Inc. | -87.62 Million USD | 24.731% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 2.695% |
| GlycoMimetics, Inc. | -40.98 Million USD | -60.929% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 283.186% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 49.757% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -35.967% |
| SciSparc Ltd. | -2.06 Million USD | -3093.995% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -450.014% |
| Minerva Neurosciences, Inc. | 41 Million USD | 260.852% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 62.389% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 6.829% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 4164.108% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 156.569% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -336.464% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 103.527% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -866.388% |
| 2seventy bio, Inc. | 181.71 Million USD | 136.296% |
| ADMA Biologics, Inc. | 90.06 Million USD | 173.231% |
| Clene Inc. | 3.34 Million USD | 2074.731% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -626.171% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -206.615% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 80.834% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -153.68% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 137.124% |
| Absci Corporation | -72.59 Million USD | 9.149% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -143.38% |
| Surrozen, Inc. | -32.66 Million USD | -101.923% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -178.566% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 1335.825% |
| Cingulate Inc. | 3.08 Million USD | 2239.565% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -2145.693% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -609.874% |
| Jaguar Health, Inc. | 29.39 Million USD | 324.409% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 16.851% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 49.825% |
| Kronos Bio, Inc. | -36.05 Million USD | -82.937% |
| Innoviva, Inc. | 255.56 Million USD | 125.808% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 800.988% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 10602.548% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -2007.882% |
| Soligenix, Inc. | -4.95 Million USD | -1232.015% |
| AlloVir, Inc. | -62.69 Million USD | -5.206% |
| Century Therapeutics, Inc. | 847 Thousand USD | 7887.013% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -400.767% |
| Kura Oncology, Inc. | -20.11 Million USD | -227.846% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 3720.584% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -33.774% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 292.471% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -3725.754% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 143.694% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -30.196% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -305.899% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -2186.228% |
| HCW Biologics Inc. | 2.85 Million USD | 2408.837% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -18.596% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 306.856% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 117.451% |
| Lantern Pharma Inc. | -21.7 Million USD | -203.899% |
| Histogen Inc. | -7.48 Million USD | -780.94% |
| Surrozen, Inc. | -32.66 Million USD | -101.923% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -1459.612% |
| Kodiak Sciences Inc. | -103.87 Million USD | 36.504% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 85.26% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -352.471% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 183311.111% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -1777.484% |
| Moderna, Inc. | -2.9 Billion USD | 97.731% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 106.256% |
| Turnstone Biologics Corp. | -14.58 Million USD | -352.249% |
| Immix Biopharma, Inc. | -17.5 Million USD | -276.681% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -6946.581% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 235.344% |
| Exelixis, Inc. | -73.05 Million USD | 9.711% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 19.627% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 60.795% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -1933.796% |
| Alkermes plc | -166.73 Million USD | 60.444% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 21.575% |
| Arcellx, Inc. | -296.95 Million USD | 77.789% |
| ESSA Pharma Inc. | -33.62 Million USD | -96.172% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -2405.794% |
| Avid Bioservices, Inc. | 169.72 Million USD | 138.86% |
| Insmed Incorporated | 721.62 Million USD | 109.14% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -238.132% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -12.027% |
| Moolec Science SA | 117.61 Thousand USD | 56177.404% |
| RenovoRx, Inc. | -1.17 Million USD | -5522.847% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -71.765% |
| Geron Corporation | 14.76 Million USD | 546.826% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -73.944% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -174.394% |
| Royalty Pharma plc | 5.65 Billion USD | 101.166% |
| OmniAb, Inc. | 9.2 Million USD | 816.679% |
| Alector, Inc. | -35.63 Million USD | -85.077% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 53.362% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 53.133% |
| Humacyte, Inc. | -22.48 Million USD | -193.32% |
| Structure Therapeutics Inc. | -124.33 Million USD | 46.955% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 119.367% |
| 89bio, Inc. | -289.05 Million USD | 77.182% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -3599.159% |
| Aura Biosciences, Inc. | -21.52 Million USD | -206.416% |
| Immunic, Inc. | -45.34 Million USD | -45.47% |
| Veracyte, Inc. | -203.82 Million USD | 67.641% |
| Genelux Corporation | -6.89 Million USD | -856.023% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -112.357% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -2233.006% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -3085.745% |
| Immunovant, Inc. | -635.22 Million USD | 89.617% |
| Vericel Corporation | 1.27 Million USD | 5264.918% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 104.203% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -169.516% |
| XBiotech Inc. | -200.02 Million USD | 67.026% |
| Agenus Inc. | 274.13 Million USD | 124.06% |
| Acasti Pharma Inc. | -23 Million USD | -186.703% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -2709.277% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -1858.762% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -305.899% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 1258.953% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 28.599% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -196.671% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -512.544% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -255.194% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -1025.529% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -12.13% |
| United Therapeutics Corporation | -507.7 Million USD | 87.009% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -1810.288% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -7550.718% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -1469.078% |
| Silo Pharma, Inc. | -3.52 Million USD | -1771.46% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 66208.711% |
| Pharming Group N.V. | 109.8 Million USD | 160.067% |
| XOMA Corporation | -29 Million USD | -127.434% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -256.137% |
| Bionomics Limited | 227 Million USD | 129.054% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -2503.869% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 746.945% |
| uniQure N.V. | -102.95 Million USD | 35.935% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -98.382% |
| Cassava Sciences, Inc. | -121.13 Million USD | 45.552% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -3248.34% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 627.184% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 261.061% |
| Pluri Inc. | 22.82 Million USD | 388.913% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -2031.601% |
| MeiraGTx Holdings plc | -40.3 Million USD | -63.654% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -113.443% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -295.131% |
| CalciMedica, Inc. | -5.53 Million USD | -1092.694% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -98.346% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 133.3% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -1075.63% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -2503.869% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -10.029% |
| Nutriband Inc. | -251.65 Thousand USD | -26108.689% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -93.312% |
| Compugen Ltd. | -12.9 Million USD | -411.128% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 98.907% |
| ProKidney Corp. | -56.23 Million USD | -17.284% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -5021.233% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -2016.442% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -140.146% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 3056.967% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -23206.007% |
| Benitec Biopharma Inc. | -50.58 Million USD | -30.394% |
| GeoVax Labs, Inc. | -6.45 Million USD | -922.163% |
| Biomea Fusion, Inc. | -166.57 Million USD | 60.403% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 30.458% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 71.866% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 31.078% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -244.85% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 36.786% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -68.802% |
| Imunon, Inc. | -4.21 Million USD | -1465.219% |
| BioAtla, Inc. | -109.01 Million USD | 39.496% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 651.195% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -211.069% |
| Zura Bio Limited | -99.8 Million USD | 33.916% |
| aTyr Pharma, Inc. | -7.44 Million USD | -785.434% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 481.734% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 19.348% |
| Galecto, Inc. | -21.21 Million USD | -210.879% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 4164.108% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 104.776% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 178.896% |
| PolyPid Ltd. | 6.17 Million USD | 1168.979% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 188.985% |
| Forte Biosciences, Inc. | -11.96 Million USD | -451.425% |
| Xencor, Inc. | 29.64 Million USD | 322.494% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -26830.929% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -5451.221% |
| Instil Bio, Inc. | 75.35 Million USD | 187.524% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -293102.934% |
| OncoCyte Corporation | -6.56 Million USD | -904.967% |
| Elevation Oncology, Inc. | -19.11 Million USD | -244.994% |
| Purple Biotech Ltd. | -14.13 Million USD | -366.516% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -177.639% |
| MacroGenics, Inc. | -66.98 Million USD | 1.536% |
| Verona Pharma plc | -220.44 Million USD | 70.08% |
| Tharimmune, Inc. | -10.93 Million USD | -503.145% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 43.279% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 8.066% |
| Aditxt, Inc. | 18.12 Million USD | 463.978% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -4607.78% |
| Savara Inc. | 153 Thousand USD | 43208.497% |
| Curis, Inc. | -23.88 Million USD | -176.117% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -8399.353% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 5665.907% |
| BeiGene, Ltd. | -2.25 Billion USD | 97.073% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -5021.233% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -537.133% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -1408.255% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -110.245% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 337.312% |
| Adicet Bio, Inc. | -138.78 Million USD | 52.477% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -1483.415% |
| Quantum-Si incorporated | -118.55 Million USD | 44.368% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -782.45% |
| Generation Bio Co. | 31.44 Million USD | 309.73% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -113.291% |
| Invivyd, Inc. | -198.47 Million USD | 66.769% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 26.935% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -2650.816% |
| Moolec Science SA | 117.61 Thousand USD | 56177.404% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 568.404% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -376.01% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -1511.999% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -1166.193% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 49.383% |
| Evaxion Biotech A/S | 5.28 Million USD | 1347.55% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 41.408% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -28.045% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1017.713% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 37.507% |
| Clearmind Medicine Inc. | -3.94 Million USD | -1572.891% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -18.065% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 50.808% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 4623.337% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -21.564% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 79.174% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -1981.287% |
| ImmunityBio, Inc. | 618.22 Million USD | 110.669% |
| Korro Bio, Inc. | -132.94 Million USD | 50.388% |
| Kineta, Inc. | -4.54 Million USD | -1352.455% |
| BioVie Inc. | -17.73 Million USD | -271.953% |
| Codexis, Inc. | -43.27 Million USD | -52.425% |
| Celularity Inc. | 65.19 Million USD | 201.175% |
| Virax Biolabs Group Limited | -3.36 Million USD | -1860.092% |
| Cibus, Inc. | -8.07 Million USD | -716.489% |
| Annexon, Inc. | -193.75 Million USD | 65.959% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -276.913% |
| Eyenovia, Inc. | 1.25 Million USD | 5340.001% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 345.144% |
| NeurAxis, Inc. | 145.7 Thousand USD | 45368.36% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -218.213% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -193.203% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -1129.866% |
| Notable Labs, Ltd. | -9.77 Million USD | -574.673% |
| IN8bio, Inc. | -16.38 Million USD | -302.441% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -1491.986% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 921.677% |
| Lumos Pharma, Inc. | -28.49 Million USD | -131.481% |
| Liquidia Corporation | -80.17 Million USD | 17.736% |
| Mustang Bio, Inc. | -3.73 Million USD | -1665.418% |
| Quantum-Si incorporated | -118.55 Million USD | 44.368% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -275.518% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 8.066% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 6.706% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -9958.408% |
| Vaxcyte, Inc. | -368.22 Million USD | 82.088% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 52.116% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -1483.415% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 435.739% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -217.496% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 4623.337% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 61.037% |
| PepGen Inc. | -60.67 Million USD | -8.713% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -187.065% |
| Solid Biosciences Inc. | -47.75 Million USD | -38.128% |
| Palisade Bio, Inc. | -12.06 Million USD | -446.763% |
| Nutriband Inc. | -251.65 Thousand USD | -26108.689% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -1933.796% |
| Immuneering Corporation | -54.94 Million USD | -20.045% |
| Belite Bio, Inc | -87.27 Million USD | 24.424% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -786.505% |
| GeoVax Labs, Inc. | -6.45 Million USD | -922.163% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 52.993% |
| Altimmune, Inc. | -134.48 Million USD | 50.957% |
| Peak Bio, Inc. | 10.34 Million USD | 737.863% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 840.663% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -789.374% |
| Neurogene Inc. | -131.95 Million USD | 50.016% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 402.329% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -1243.573% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 82.514% |
| Sesen Bio, Inc. | -112.55 Million USD | 41.4% |
| argenx SE | -2.02 Billion USD | 96.749% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 435.739% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 49.935% |
| Immunome, Inc. | -97.02 Million USD | 32.024% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -2782.721% |
| Design Therapeutics, Inc. | -18.15 Million USD | -263.394% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 687.215% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 33.952% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -69.005% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 20.804% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 514.86% |
| Athira Pharma, Inc. | -88.99 Million USD | 25.891% |
| XOMA Corporation | -29 Million USD | -127.434% |
| Merus N.V. | -192.88 Million USD | 65.805% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -850.649% |
| Rezolute, Inc. | -68.16 Million USD | 3.245% |
| Clene Inc. | 3.34 Million USD | 2074.731% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -400.159% |
| BeyondSpring Inc. | -13.75 Million USD | -379.506% |
| Synlogic, Inc. | -6.68 Million USD | -886.627% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 5916.226% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -680.083% |
| Peak Bio, Inc. | 10.34 Million USD | 737.863% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 19.976% |
| Krystal Biotech, Inc. | -350.23 Million USD | 81.168% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 153.137% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 60.972% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -1989.103% |
| MannKind Corporation | 143.89 Million USD | 145.835% |
| Ikena Oncology, Inc. | -109.15 Million USD | 39.576% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -771.166% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -99.263% |
| Gossamer Bio, Inc. | 180.35 Million USD | 136.57% |
| CohBar, Inc. | -5.93 Million USD | -1012.106% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -121.716% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 1544.503% |
| Legend Biotech Corporation | -949.39 Million USD | 93.053% |
| Mural Oncology plc | -255.84 Million USD | 74.22% |
| Disc Medicine, Inc. | -358.28 Million USD | 81.591% |
| Champions Oncology, Inc. | 4.81 Million USD | 1470.657% |
| REGENXBIO Inc. | 54.76 Million USD | 220.428% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -24427.439% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 56.327% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -631.868% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 18.253% |
| Vaxart, Inc. | -8.24 Million USD | -700.34% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -31.439% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 48.134% |
| Cellectis S.A. | -43.85 Million USD | -50.396% |
| Longeveron Inc. | -2.9 Million USD | -2168.088% |
| Repare Therapeutics Inc. | -107.85 Million USD | 38.849% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 106.811% |
| Inozyme Pharma, Inc. | 12 Million USD | 649.45% |
| Revolution Medicines, Inc. | -608.2 Million USD | 89.156% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -5262.276% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 75.122% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 56.05% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -321.525% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -8812.973% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 99.31% |
| Denali Therapeutics Inc. | -74.86 Million USD | 11.9% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -450.014% |
| Veru Inc. | 4.77 Million USD | 1479.842% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -486.484% |
| Cingulate Inc. | 3.08 Million USD | 2239.565% |
| Passage Bio, Inc. | 4.58 Million USD | 1538.517% |
| Context Therapeutics Inc. | -14.44 Million USD | -356.448% |
| Exicure, Inc. | 5.84 Million USD | 1227.646% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 71.37% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -66.682% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 520.343% |
| Nuvalent, Inc. | -335.38 Million USD | 80.334% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 3902.943% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 11.447% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -641.912% |
| OmniAb, Inc. | 9.2 Million USD | 816.679% |
| Anew Medical, Inc. | 1.43 Million USD | 4704.371% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 502.619% |
| Lipocine Inc. | -4.75 Million USD | -1287.206% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 39.946% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 533.038% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -30.196% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 364.969% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -881.342% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -0.196% |
| Ocugen, Inc. | -32.52 Million USD | -102.81% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 22.926% |
| Q32 Bio Inc. | -37.94 Million USD | -73.806% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -10402.548% |
| Alumis Inc. Common Stock | -13.52 Million USD | -387.516% |
| Equillium, Inc. | -22.39 Million USD | -194.552% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -157.963% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -102.153% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -26504.28% |
| Dominari Holdings Inc. | 195 Thousand USD | 33923.59% |
| Edesa Biotech, Inc. | -5.26 Million USD | -1152.271% |
| vTv Therapeutics Inc. | -8.91 Million USD | -639.666% |
| Bio-Techne Corporation | 267.74 Million USD | 124.634% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -306.91% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 44.15% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -684.91% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -421.35% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 73.092% |
| Nkarta, Inc. | 57.29 Million USD | 215.108% |
| BioCardia, Inc. | 212 Thousand USD | 31211.321% |
| Iterum Therapeutics plc | 13.43 Million USD | 590.817% |